Researchers have found that obesity is associated with clinician- and patient-assessed severity of atopic dermatitis (AD), ...

Atopic dermatitis (AD) negatively impacts patients' mental health (MH), especially when a patient has severe AD, according to ...

Among patients with moderate to severe atopic dermatitis, upadacitinib was found to be superior to dupilumab for skin clearance and itch resolution, according to results from a head-to-head phase 3b/4 ...

si-544 was well tolerated with no serious adverse effects, dose limiting toxicities, or safety signals observed75% of patients receiving si-544 ...

Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. With several ...

A regulatory decision is expected in the fourth quarter of 2024. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for tapinarof cream, 1% for the ...

Researchers have found that the use of antibiotics early in life is linked to an increased risk of developing atopic ...

The following is a summary of "Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative ...

ASLAN management will present new data from the interim analysis of the TREK-DX studyRegister here to attend the webinar ...

Australian researchers find that higher neonatal vitamin D levels are associated with lower odds of early-onset persistent ...

For the second time in four years, AbbVie’s Rinvoq (upadacitinib) has shown superior efficacy to Regeneron and Sanofi’s ...

The acquisition will give Incyte two dermatology drugs currently being investigated for several inflammatory skin diseases.